Abits
ABTS
CleanSpark
CLSK
MicroStrategy
MSTR
FRMO CORP
FRMO
Ebang International
EBON
US Stock MarketDetailed Quotes
GDTC CytoMed Therapeutics
- 2.260
- -0.500-18.12%
Close Jan 13 16:00 ET
- 2.350
- +0.090+3.98%
Post 17:59 ET
26.08MMarket Cap-11.65P/E (TTM)
2.840High2.180Low88.85KVolume2.840Open2.760Pre Close218.11KTurnover2.51%Turnover RatioLossP/E (Static)11.54MShares4.30052wk High3.52P/B8.01MFloat Cap1.20052wk Low--Dividend TTM3.55MShs Float9.250Historical High--Div YieldTTM23.90%Amplitude1.200Historical Low2.454Avg Price1Lot Size
CytoMed Therapeutics Key Stats
EPS
According to the latest financial report of CytoMed Therapeutics, the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: SGD
Quarterly
Loading...
FCF
Interested in knowing about CytoMed Therapeutics's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: SGD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of CytoMed Therapeutics shows that the company's current ratio is 21.53, indicating healthy liquidity.
Currency: SGD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of CytoMed Therapeutics, the quick ratio is 18.22, indicating that the company can meet its short-term debt obligations.
Currency: SGD
Quarterly
Loading...
ROE
Want to learn more about the financial health of CytoMed Therapeutics? The latest ROE figure is --, indicating that the company has stable profitability.
Currency: SGD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of CytoMed Therapeutics, the total asset return on investment (ROA) is --.
Currency: SGD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check CytoMed Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: SGD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of CytoMed Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: SGD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
